SVM 26th Scientific Sessions: Message from the Scientific Program Committee Chair
(Source: Vascular Medicine)
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Bartholomew, J. R. Tags: Society for Vascular Medicine Communication Page Source Type: research
Thrombophilia
(Source: Vascular Medicine)
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Lim, M. Y., Moll, S. Tags: Vascular Disease Patient Information Page Source Type: research
Removal of floating inferior vena cava thrombus with the AngioVac device
(Source: Vascular Medicine)
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Johnson, A. M., Bjarnason, H., Shields, R., Shih, H., McBane, R., De Martino, R. R. Tags: Images in Vascular Medicine Source Type: research
Venous thoracic outlet syndrome
is a complex but rare disease that often can have excellent outcomes if quickly recognized and treated. The syndrome results from compression of the subclavian vein along its exit from the thoracic cavity and frequently affects young otherwise healthy patients. Modern diagnosis is made with a combination of clinical exam, appropriate non-invasive imaging, and, finally, contrast venography, which can be both diagnostic and therapeutic. Treatments have evolved over time to the point where patients can undergo less extensive procedures than previously performed and still maintain excellent outcomes. One of the most important...
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Moore, R., Wei Lum, Y. Tags: Review Articles Source Type: research
Venous leg ulceration pathophysiology and evidence based treatment
Venous leg ulceration (VLU) is one of the most predominate medical disorders worldwide and in the western hemisphere it affects around 1.5% of the general population and up to 5% of the elderly population. Unfortunately, this trend will only increase given the growth of an aging population worldwide. Understanding its pathophysiology that begins with venous hemodynamic abnormalities and leads to inflammatory alterations with microcirculatory changes is critical to delivering effective curative therapy. As such, the main component to treatment is reversing the underlying venous hypertension and pro-inflammatory milieu using...
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Chi, Y.-W., Raffetto, J. D. Tags: Review Articles Source Type: research
Surgical hardware-related iatrogenic venous compression syndrome
In this report, we describe two cases of DVT related to IAVC, and review similar cases that have been previously reported in the literature. With advancements in catheter-based technology, patients with IAVC (with or without DVT) may now be offered advanced endovascular treatment options such as catheter-directed pharmacomechanical thrombolysis (PMT) and percutaneous venoplasty and/or stenting. Hence, timely recognition and treatment is essential in the prevention of disabling PTS or life-threatening pulmonary embolism. (Source: Vascular Medicine)
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Mathur, M., Shafi, I., Alkhouli, M., Bashir, R. Tags: Review Articles Source Type: research
Approach to chemotherapy-associated thrombosis
Treatment of cancer patients with antineoplastic agents is associated with a heightened risk of thrombotic events, both arterial and venous. In this article, we review the specific agents that are implicated and the pathophysiological processes that are known to be associated with this prothrombotic state. We conclude with current recommendations for prophylactic antithrombotic therapy in these clinical situations. (Source: Vascular Medicine)
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Oppelt, P., Betbadal, A., Nayak, L. Tags: Review Articles Source Type: research
Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation
Initial treatment for venous thromboembolism (VTE) includes the acute and intermediate phases, usually lasting for 3 months. The choice to extend therapy beyond the initial 3-month window involves assessing a combination of risk factors for VTE recurrence and bleeding, along with weighing patient preferences. In some cases, such as VTE provoked by a reversible surgical risk factor, the recurrence risk is sufficiently low that most patients should not receive extended therapy. In other cases, such as VTE associated with malignancy, the recurrence risk is sufficiently high that treatment should be extended beyond the initial...
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Barnes, G. D., Kanthi, Y., Froehlich, J. B. Tags: Review Articles Source Type: research
Pharmacomechanical thrombectomy and catheter-directed thrombolysis of acute lower extremity deep venous thrombosis in a 9-year-old boy with inferior vena cava atresia
We report a case of iliofemoral DVT in a 9-year-old boy with IVC atresia and presumed protein S deficiency that was treated successfully using pharmacomechanical thrombectomy and catheter-directed thrombolysis. He was maintained on long-term anticoagulation and remained symptom free at 6 months’ follow-up. (Source: Vascular Medicine)
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Jahromi, A. H., Coulter, A. H., Bass, P., Zhang, W. W., Tan, T.-W. Tags: Case Report Source Type: research
Comparative efficacy of different modalities for treatment of right heart thrombi in transit: A pooled analysis
In conclusion, left untreated, patients with RHT and PE have very high mortality. Aggressive management with thrombolysis or surgical thrombectomy may be more effective than AC alone in the management of these patients. (Source: Vascular Medicine)
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Athappan, G., Sengodan, P., Chacko, P., Gandhi, S. Tags: Original Articles Source Type: research
A retrospective analysis of catheter-based thrombolytic therapy for acute submassive and massive pulmonary embolism
Catheter-based thrombolysis (CBT) is emerging as an option for acute pulmonary embolism (PE). Although prior studies have demonstrated improvement in right ventricular function, little data is available regarding clinical patient outcomes. Our institution adopted CBT as an option for patients with submassive and massive PE and we evaluated its effect on patient outcomes. Two hundred and twenty-one patients who presented to our institution with submassive and massive PE were analyzed over three years by time period; 102 prior to the use of CBT and 119 during the time CBT was performed. The primary outcome was in-hospital ma...
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: George, B., Wallace, E. L., Charnigo, R., Wingerter, K. E., Kapadia, P., Gurley, J. C., Smyth, S. S. Tags: Original Articles Source Type: research
Postoperative prophylaxis of venous thromboembolism (VTE) in patients undergoing high ligation and stripping of the great saphenous vein (GSV)
In conclusion, postoperative VTE chemoprophylaxis following high ligation and GSV stripping effectively reduces the venous thrombosis complications of this procedure. Of the three active strategies tested, no difference in efficacy was noted; however, thrice daily LDUH did increase bleeding complications. (Source: Vascular Medicine)
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Wang, H., Sun, Z., Jiang, W., Zhang, Y., Li, X., Wu, Y. Tags: Original Articles Source Type: research
Low incidence of post-thrombotic syndrome in patients treated with new oral anticoagulants and percutaneous endovenous intervention for lower extremity deep venous thrombosis
This report sought to evaluate the role of PEVI plus NOACs in the reduction of PTS in acute symptomatic femoropopliteal and iliac DVT. We studied 127 patients with acute lower extremity DVT who had undergone PEVI plus administration of NOACs. All had received a minimum of 3 months of anticoagulation with a NOAC following PEVI. The mean follow-up was 22±5 months. The patients were evaluated for development of PTS, bleeding, recurrent venous thromboembolism (VTE), duration of hospitalization and mortality. There was no in-hospital bleeding. The mean duration of hospitalization was 46±9 hours. DVT occurred in tw...
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Sharifi, M., Freeman, W., Bay, C., Sharifi, M., Schwartz, F. Tags: Original Articles Source Type: research
Association of foot and ankle characteristics with progression of venous disease
Although risk factors have been identified for the cross-sectional prevalence of venous disease, few studies have investigated risk factors for venous disease progression. Therefore, the aim of this study was to investigate the relationship between foot and ankle characteristics and the progression of venous disease. A total of 1025 participants from the San Diego Population Study were assessed at baseline and at follow-up 11 years later. Risk factors were assessed by questionnaire and physical measurements, while venous disease was determined by physical examination and Duplex ultrasound. Change in venous disease from bas...
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Kim, T. I., Forbang, N. I., Criqui, M. H., Allison, M. A. Tags: Original Articles Source Type: research
Beyond Virchow's Triad: Does cardiovascular inflammation explain the recurrent nature of venous thromboembolism?
(Source: Vascular Medicine)
Source: Vascular Medicine - April 1, 2015 Category: Internal Medicine Authors: Piazza, G. Tags: Editorials Source Type: research
